rMark Bio helps pharmaceutical companies identify academic and clinical partners for collaboration during drug development.
rMark Bio applies deep learning algorithms and analytics to help pharmaceutical companies identify academic researchers and clinicians to partner with during drug research and development. Our solution reduces the significant man hours wasted manually gathering and understanding information about academic scientists (approx. $1-$2 Billion/year in wasted costs), while simultaneously providing higher value partnership opportunities. rMark Bio was founded by Jason Smith and Dr. Lev Becker. Starting in the summer of 2015, the founders boot-strapped rMark Bio to create the proof of concept, protect intellectual property, establish relationships with pharmaceutical companies, establish an Advisory Board with industry leaders, create a user committee drive our MVP requirements, and validate the “need” (i.e business opportunity).